WA
KLRS

Wasatch Advisors’s Kalaris Therapeutics KLRS Stock Holding History

Wasatch Advisors’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$2.57M Sell
2023
Q3 		$13.6M Sell
2023
Q2 		$22.6M Buy
2023
Q1 		$4.96M Buy